Mechanisms of Sequence-Based Resistance to Viruses and Plasmids in Eubacteria

真细菌基于序列的病毒和质粒抗性机制

基本信息

  • 批准号:
    7600253
  • 负责人:
  • 金额:
    $ 7.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-12-15 至 2010-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In recent years, it has become clear that many organisms exploit the base-pairing potential of RNA and DNA to enable sequence-based resistance mechanisms against viruses and other mobile genetic elements. The best known of these mechanisms, RNA interference, uses double-stranded RNA to trigger the silencing of specific genes. However, this mechanism has thus far only been documented in eukaryotes. More recently, clustered regularly interspaced short palindromic repeat (CRISPR) loci, present in the genomes of many eubacteria and nearly all archaebacteria, have been shown to confer sequence-based immunity against bacteriophages. CRISPR loci are accompanied by a set of cas (CRISPR-associated) genes that are likely to encode protein components of the underlying enzymatic machinery. However, the biochemical mechanism of CRISPR- and cas-directed interference is unknown. We propose to dissect the molecular basis for CRISPR and cas gene function. Genome database searches have revealed the presence of a relatively simple CRISPR/cas locus in a strain of Staphylococcus epidermidis, and the sequence of the locus suggests that it specifies resistance not only to bacteriophages but also to staphylococcal conjugative plasmids. Given the clinical importance of staphylococci and the experimental tractability of S. epidermidis, we will use it as a model system to explore fundamental aspects of CRISPR-derived immunity in eubacteria. Preliminary results confirm that an S. epidermidis strain carrying the CRISPR locus is defective as a plasmid conjugation recipient, whereas an isogenic strain lacking the CRISPR locus is not. These and other observations confirm a role for CRISPR loci in restricting horizontal gene transfer in eubacteria, and provide us with a simple and convenient assay for CRISPR function. We will use this system to conduct a genetic analysis of CRISPR and cas gene function. In particular, we will define the sequence characteristics of both the CRISPR locus and the target plasmid that are needed for interference, and we will test the involvement of specific cas genes in this process. In addition, we will conduct preliminary biochemical analyses of the previously reported CRISPR transcripts. The results of these experiments will place critical constraints on viable models of CRISPR/cas function, and will set the stage for in-depth mechanistic analyses. S. epidermidis and Staphylococcus aureus are the most common causes of nosocomial infections, and the transfer of plasmids that carry antimicrobial resistance genes contributes to the ever-worsening spread of these pathogens. Understanding CRISPR function is an important step in the development of therapeutic interventions that exploit this pathway to impede the spread of antibiotic resistance. In addition, given the important role of bacteriophages in the evolution of pathogenic bacteria, the study of CRISPR function will improve our understanding of how infectious diseases emerge, disappear and re-emerge. PUBLIC HEALTH RELEVANCE: Clustered regularly interspaced short palindromic repeat (CRISPR) loci confer acquired, sequence-based resistance against viruses and conjugative plasmids in many eubacteria and nearly all archaebacteria, but the underlying mechanisms are unknown. The transfer of antibiotic resistance genes on conjugative plasmids contributes to the spread of pathogenic bacterial strains, leading to significant threats to human health. The proposed studies will clarify the mechanisms of CRISPR function, and will therefore contribute to our ability to exploit this natural pathway to prevent and treat infectious disease.
描述(由申请人提供):近年来,已经清楚的是,许多生物体利用RNA和DNA的碱基配对潜力来实现针对病毒和其他移动遗传元件的基于序列的抵抗机制。这些机制中最著名的是 RNA 干扰,它使用双链 RNA 触发特定基因的沉默。然而,迄今为止,这种机制仅在真核生物中得到记录。最近,许多真细菌和几乎所有古细菌基因组中存在的成簇规则间隔短回文重复(CRISPR)基因座已被证明能够赋予针对噬菌体的基于序列的免疫力。 CRISPR 位点伴随着一组 cas(CRISPR 相关)基因,这些基因可能编码潜在酶促机制的蛋白质成分。然而,CRISPR 和 cas 定向干扰的生化机制尚不清楚。我们建议剖析 CRISPR 和 cas 基因功能的分子基础。基因组数据库搜索揭示了表皮葡萄球菌菌株中存在相对简单的 CRISPR/cas 基因座,该基因座的序列表明它不仅对噬菌体具有抗性,而且还对葡萄球菌接合质粒具有抗性。鉴于葡萄球菌的临床重要性和表皮葡萄球菌的实验易处理性,我们将使用它作为模型系统来探索真细菌中 CRISPR 衍生免疫的基本方面。初步结果证实,携带 CRISPR 基因座的表皮葡萄球菌菌株作为质粒接合受体存在缺陷,而缺乏 CRISPR 基因座的同基因菌株则没有。这些和其他观察结果证实了 CRISPR 位点在限制真细菌水平基因转移中的作用,并为我们提供了一种简单方便的 CRISPR 功能测定方法。我们将利用该系统对CRISPR和cas基因功能进行遗传分析。特别是,我们将定义干扰所需的CRISPR位点和目标质粒的序列特征,并且我们将测试特定cas基因在此过程中的参与。此外,我们将对之前报道的CRISPR转录本进行初步生化分析。这些实验的结果将对 CRISPR/cas 功能的可行模型施加关键限制,并为深入的机制分析奠定基础。表皮葡萄球菌和金黄色葡萄球菌是医院感染的最常见原因,携带抗菌素耐药基因的质粒的转移导致这些病原体的传播不断恶化。了解 CRISPR 功能是开发治疗干预措施的重要一步,利用该途径阻止抗生素耐药性的传播。此外,鉴于噬菌体在病原菌进化中的重要作用,对CRISPR功能的研究将提高我们对传染病如何出现、消失和重新出现的理解。公共健康相关性:成簇的规则间隔短回文重复序列 (CRISPR) 位点赋予许多真细菌和几乎所有古细菌对病毒和接合质粒的获得性、基于序列的抵抗力,但其潜在机制尚不清楚。接合质粒上抗生素抗性基因的转移有助于致病菌株的传播,对人类健康造成重大威胁。拟议的研究将阐明 CRISPR 功能的机制,从而有助于我们利用这种自然途径来预防和治疗传染病的能力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIK J. SONTHEIMER其他文献

ERIK J. SONTHEIMER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIK J. SONTHEIMER', 18)}}的其他基金

Advanced Delivery Platforms for Base Editing In Vivo
用于体内碱基编辑的先进交付平台
  • 批准号:
    10682172
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
Enhancing Genome Editing Technology with Natural Cas9 Inhibitors
利用天然 Cas9 抑制剂增强基因组编辑技术
  • 批准号:
    10092186
  • 财政年份:
    2018
  • 资助金额:
    $ 7.63万
  • 项目类别:
Engineered Cas9 Nucleases with Single-Genomic-Site Precision for CYBB Correction
用于 CYBB 校正的具有单基因组位点精度的工程化 Cas9 核酸酶
  • 批准号:
    9272917
  • 财政年份:
    2016
  • 资助金额:
    $ 7.63万
  • 项目类别:
Center for 3D Structure and Physics of the Genome
基因组 3D 结构和物理中心
  • 批准号:
    9021492
  • 财政年份:
    2015
  • 资助金额:
    $ 7.63万
  • 项目类别:
Mechanisms of CRISPR Interference
CRISPR 干扰机制
  • 批准号:
    7918429
  • 财政年份:
    2010
  • 资助金额:
    $ 7.63万
  • 项目类别:
Mechanisms of CRISPR Interference
CRISPR 干扰机制
  • 批准号:
    8050679
  • 财政年份:
    2010
  • 资助金额:
    $ 7.63万
  • 项目类别:
Mechanisms of CRISPR Interference
CRISPR 干扰机制
  • 批准号:
    8424275
  • 财政年份:
    2010
  • 资助金额:
    $ 7.63万
  • 项目类别:
Mechanisms of CRISPR Interference
CRISPR 干扰机制
  • 批准号:
    8228116
  • 财政年份:
    2010
  • 资助金额:
    $ 7.63万
  • 项目类别:
Mechanisms of Sequence-Based Resistance to Viruses and Plasmids in Eubacteria
真细菌基于序列的病毒和质粒抗性机制
  • 批准号:
    7748988
  • 财政年份:
    2008
  • 资助金额:
    $ 7.63万
  • 项目类别:
Improvement of RNAi efficacy by blocking RNAi inhibitors
通过阻断 RNAi 抑制剂提高 RNAi 功效
  • 批准号:
    7109912
  • 财政年份:
    2006
  • 资助金额:
    $ 7.63万
  • 项目类别:

相似国自然基金

多环芳烃影响大肠杆菌抗生素耐药性进化的分子机制
  • 批准号:
    32301424
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
靶向铜绿假单胞菌FpvA蛋白的铁载体偶联抗生素克服细菌耐药性及作用机制研究
  • 批准号:
    82304313
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
乙醇脱氢酶AdhB介导肺炎链球菌抗生素耐药性的机制研究
  • 批准号:
    32300154
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
鸭肠道菌群抗生素耐药性分布及替抗噬菌体内溶素鉴定研究
  • 批准号:
    32360830
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
胞外DNA对厌氧颗粒污泥抗生素耐药性转移的影响及作用机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目

相似海外基金

Development of Targeted Antipseudomonal Bactericidal Prodrugs
靶向抗假单胞菌杀菌前药的开发
  • 批准号:
    10678074
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
  • 批准号:
    10649771
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
Development of a model of Gonococcal conjunctivitis for vaccine evaluations
开发用于疫苗评估的淋菌性结膜炎模型
  • 批准号:
    10740430
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
Commercialization Readiness Pilot (CRP) program support for: Direct-from-specimen identification of pathogens common in endocarditis
商业化准备试点 (CRP) 计划支持: 直接从样本鉴定心内膜炎常见病原体
  • 批准号:
    10758417
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
A Randomized Pilot and Feasibility Study of a cultuRE-Directed approach to Urinary traCT Infection symptoms in older womeN: a mixed methods evaluation - the REDUCTION trial
针对老年女性尿路感染症状的文化导向方法的随机试验和可行性研究:混合方法评估 - REDUCTION 试验
  • 批准号:
    10586250
  • 财政年份:
    2023
  • 资助金额:
    $ 7.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了